Daniel Kohlstaedt, managing director at PurpleLeaf Strategy, discusses how new technologies can help bring brand planning and strategy development into the digital age.
When pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital that they understand what makes their healthcare customers tick.
Over the years, pharmaceutical companies have adapted to new methods of marketing thanks to technological innovation and a constantly-evolving stakeholder landscape.
Brand management in pharma has changed beyond recognition, from the glory days of large molecules and opulent pipelines to a space where marketers have to be real marketers. In his article in <
A new report from Kantar Health sets out how brand leaders can identify key levers for driving growth within each pillar, from launch through to managing decline, and elevate the opportunities
In an industry growing as quickly as cell therapy, keeping up with the demands of manufacturing and treatment is a challenge for the whole industry to tackle together, including stakeholder
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho